For example, an EGFR splice variant, lacks exon 4 (de4 EGFR), was found to constitutively activate downstream pathways to promote cancer cell proliferation and metastasis in glioma, prostate cancer, and ovarian cancer tissues [17]. This evidence concerns the gene EGFR and ovarian cancer.